Analyst Ranking
Top 11%
#525 out of 4906 analysts
Average Return
+8.89%
Win Rate
56%63 out of 112
Risk vs Reward
Poor
Good

David Amsellem's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Amneal Pharmaceuticals IncAMRX
+222.28%$2.02$6.51
2023-05-08 -
2024-05-07
Strong Buy
Horizon Therapeutics Public Ltd CoHZNP
+189.77%$31.56$91.45
2020-04-14 -
2021-04-14
Strong Buy
Corcept Therapeutics IncCORT
+114.45%$32.67$70.06
2024-07-01 -
2025-06-13
Strong Buy
Xeris Biopharma Holdings IncXERS
+105.93%$1.69$3.47
2023-11-10 -
2024-11-08
Strong Buy
Corcept Therapeutics IncCORT
+93.96%$36.12$70.06
2024-07-30 -
2025-06-13
Strong Buy

David Amsellem Analyst Color

Get additional color on David Amsellem's coverage of popular stocks

David Amsellem's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biogen IncBIIB
1Hold$115.00-11.98%Reiterates
4 days ago
Amgen IncAMGN
3Strong Buy$328.00+11.10%Maintains
a month ago
Organon & CoOGN
6Strong Buy$18.00+79.28%Maintains
a month ago
Collegium Pharmaceutical IncCOLL
7Hold$37.00+26.80%Reiterates
a month ago
Jazz Pharmaceuticals PLCJAZZ
9Strong Buy$147.00+35.48%Reiterates
a month ago
Neurocrine Biosciences IncNBIX
7Strong Buy$154.00+23.80%Reiterates
a month ago
Bristol Myers Squibb CoBMY
1Strong Buy$65.00+30.65%Initiates Coverage On
2 months ago
Corcept Therapeutics IncCORT
7Strong Buy$131.00+86.98%Maintains
2 months ago
Amphastar Pharmaceuticals IncAMPH
7Hold$32.00+23.93%Maintains
3 months ago
Optinose IncOPTN
3Hold$9.00-6.25%Downgrades
3 months ago
Xeris Biopharma Holdings IncXERS
5Hold$4.00-8.05%Reiterates
3 months ago
Indivior PLCINDV
5Strong Buy$13.00-6.41%Maintains
3 months ago
Viatris IncVTRS
7Hold$10.00+12.11%Reiterates
3 months ago
Teva Pharmaceutical Industries LtdTEVA
7Strong Buy$30.00+76.57%Maintains
5 months ago
Intra Cellular Therapies IncITCI
1Hold$132.00+0.10%Downgrades
5 months ago
Avadel Pharmaceuticals PLCAVDL
4Strong Buy$13.00+35.84%Maintains
5 months ago
Sage Therapeutics IncSAGE
1Strong Buy$9.00+34.33%Maintains
5 months ago
Amneal Pharmaceuticals IncAMRX
4Strong Buy$11.00+41.94%Maintains
7 months ago
Alkermes PLCALKS
7Strong Buy$37.00+24.04%Reiterates
8 months ago
Ani Pharmaceuticals IncANIP
1Strong Buy$68.00+8.70%Initiates Coverage On
8 months ago
Supernus Pharmaceuticals IncSUPN
10Hold$36.00+12.39%Downgrades
9 months ago
Revance Therapeutics IncRVNC
7Strong Buy$6.00+64.38%Maintains
10 months ago
Bausch Health Companies IncBHC
4Strong Sell$3.00-49.83%Downgrades
10 months ago
Pacira Biosciences IncPCRX
7Strong Buy$42.00+73.27%Maintains
a year ago
Aquestive Therapeutics IncAQST
1Strong Buy$10.00N/AInitiates Coverage On
a year ago
Ironwood Pharmaceuticals IncIRWD
3Strong Buy$21.00N/AMaintains
a year ago
Axsome Therapeutics IncAXSM
3Strong Buy$113.00N/AMaintains
a year ago
Cerevel Therapeutics Holdings IncCERE
2Hold$45.00N/ADowngrades
2 years ago
Tvardi Therapeutics IncTVRD
3Hold$12.00N/ADowngrades
2 years ago
Harmony Biosciences Holdings IncHRMY
3Strong Buy$42.00N/AMaintains
2 years ago
Eagle Pharmaceuticals IncEGRX
2Strong Sell$17.00N/ADowngrades
2 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$285.00N/AInitiates Coverage On
2 years ago
Horizon Therapeutics Public Ltd CoHZNP
3Strong Buy$110.00N/AMaintains
3 years ago
Antares Pharma IncATRS
1Hold$5.60N/ADowngrades
3 years ago
Endo International PLCENDPQ
3Hold$3.00N/AMaintains
3 years ago
Biodelivery Sciences International IncBDSI
1Hold$5.60N/ADowngrades
3 years ago
Adamas Pharmaceuticals IncADMS
1Hold$8.00N/ADowngrades
4 years ago
Evofem Biosciences IncEVFM
1Strong Buy$165.00N/AInitiates Coverage On
5 years ago
Impax Laboratories IncIPXL
1HoldN/AN/AUpgrades
8 years ago
Societal Cdmo IncSCTL
1Strong Buy$12.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.